168 related articles for article (PubMed ID: 15627843)
1. Serum antibodies to retinal antigens in lung cancer and sarcoidosis.
Jankowska R; Witkowska D; Porebska I; Kuropatwa M; Kurowska E; Gorczyca WA
Pathobiology; 2004; 71(6):323-8. PubMed ID: 15627843
[TBL] [Abstract][Full Text] [Related]
2. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
3. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors.
Bazhin AV; Savchenko MS; Shifrina ON; Demoura SA; Chikina SY; Jaques G; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2004 May; 44(2):193-8. PubMed ID: 15084384
[TBL] [Abstract][Full Text] [Related]
4. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
5. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer.
He P; Naka T; Serada S; Fujimoto M; Tanaka T; Hashimoto S; Shima Y; Yamadori T; Suzuki H; Hirashima T; Matsui K; Shiono H; Okumura M; Nishida T; Tachibana I; Norioka N; Norioka S; Kawase I
Cancer Sci; 2007 Aug; 98(8):1234-40. PubMed ID: 17506794
[TBL] [Abstract][Full Text] [Related]
7. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients.
Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW
Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated retinopathy in patients with breast carcinoma.
Misiuk-Hojło M; Ejma M; Gorczyca WA; Szymaniec S; Witkowska D; Fortuna W; Miedzybrodzki R; Rogozińska-Szczepka J; Bartnik W
Arch Immunol Ther Exp (Warsz); 2007; 55(4):261-5. PubMed ID: 17659379
[TBL] [Abstract][Full Text] [Related]
9. Low titre autoantibodies against recoverin in sera of patients with small cell lung cancer but without a loss of vision.
Bazhin AV; Shifrina ON; Savchenko MS; Tikhomirova NK; Goncharskaia MA; Gorbunova VA; Senin II; Chuchalin AG; Philippov PP
Lung Cancer; 2001 Oct; 34(1):99-104. PubMed ID: 11557119
[TBL] [Abstract][Full Text] [Related]
10. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy.
Savchenko MS; Bazhin AV; Shifrina ON; Demoura SA; Kogan EA; Chuchalin AG; Philippov PP
Lung Cancer; 2003 Sep; 41(3):363-7. PubMed ID: 12928127
[TBL] [Abstract][Full Text] [Related]
11. Serum antibodies against recoverin and Hu: two paraneoplastic epiphenomena in lung cancer.
Drlicek M; Unterberger U; Voigtländer ; Grisold W
Lung Cancer; 2005 Jan; 47(1):143-4; author reply 145-6. PubMed ID: 15700363
[No Abstract] [Full Text] [Related]
12. Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration.
Joachim SC; Bruns K; Lackner KJ; Pfeiffer N; Grus FH
Graefes Arch Clin Exp Ophthalmol; 2007 May; 245(5):619-26. PubMed ID: 17058093
[TBL] [Abstract][Full Text] [Related]
13. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
Ohguro H; Ogawa K; Nakagawa T
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
[TBL] [Abstract][Full Text] [Related]
14. Anti-α-enolase is a prognostic marker in postoperative lung cancer patients.
Hsiao KC; Shih NY; Chu PY; Hung YM; Liao JY; Chou SW; Yang YY; Chang GC; Liu KJ
Oncotarget; 2015 Oct; 6(33):35073-86. PubMed ID: 26551021
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
Adamus G; Machnicki M; Seigel GM
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of the aberrant expression of a paraneoplastic antigen, recoverin, in small cell lung cancer cell lines.
Bazhin AV; Savchenko MS; Belousov EV; Jaques G; Philippov PP
Lung Cancer; 2004 Sep; 45(3):299-305. PubMed ID: 15301870
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
Lundberg K; Kinloch A; Fisher BA; Wegner N; Wait R; Charles P; Mikuls TR; Venables PJ
Arthritis Rheum; 2008 Oct; 58(10):3009-19. PubMed ID: 18821669
[TBL] [Abstract][Full Text] [Related]
19. [Proteome analysis of autoantibodies in sera of patients with cancer].
Ueda K
Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma.
Salgia R; Hedges TR; Rizk M; Reimer RH; Skarin AT
Lung Cancer; 1998 Nov; 22(2):149-52. PubMed ID: 10022222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
